Quick Answer
Skye Bioscience, Inc. reported Stockholders Equity of $20.02 million for fiscal year 2025.
Skye Bioscience, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $20.02M | -70.6% |
| 2024 | $68.15M | +3296.9% |
| 2023 | -$2.13M | +29.1% |
| 2022 | -$3.01M | -151.3% |
| 2021 | $5.86M | +1200.9% |
| 2020 | $450.8K | -17.7% |
| 2019 | $548.1K | +103.5% |
| 2018 | -$15.56M | -336.0% |
| 2017 | -$3.57M | -22.5% |
| 2016 | -$2.91M | -226.6% |
| 2015 | -$892.2K | -96.7% |
| 2014 | -$453.5K | -149.0% |
| 2013 | -$182.2K | -318.5% |
| 2013 | $83.4K | +235.0% |
| 2012 | -$61.8K | -260.1% |
| 2012 | $38.6K | +48.6% |
| 2011 | $25.9K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.84M | -56.7% | -24.8% |
| June 30, 2025 | $43.68M | -40.0% | -26.3% |
| March 31, 2025 | $59.25M | -24.9% | -13.1% |
| December 31, 2024 | $68.15M | +3296.9% | -10.1% |
| September 30, 2024 | $75.80M | +4371.5% | +4.1% |
| June 30, 2024 | $72.81M | +1034.7% | -7.7% |
| March 31, 2024 | $78.88M | +1750.1% | +3800.3% |
| December 31, 2023 | -$2.13M | +29.1% | -225.8% |
- Skye Bioscience, Inc. showed a decrease of -70.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Skye Bioscience, Inc.’s stockholders equity has grown by 77064.5% (from $25.9 thousand to $20.02 million).
- The most recent figure is from Skye Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: